# EVER Pharma GmbH

Company profile · SME (from the award notice)

- Legal form: GmbH
- Seat: Gröbenzell, Germany

Based on the notices and sources Inteliwert covers; not a complete record. Last checked 22 September 2026.

## Identifiers

Not found in the indexed notices.

## Track record in public tenders

Awards in the covered notices over the last 36 months, per CPV division.

| CPV division | Awards | Award value (excl. VAT) | Buyers | Repeat buyers | First award | Last award |
| --- | ---: | ---: | ---: | ---: | --- | --- |
| 33 Medical equipments, pharmaceuticals and personal care products | 1 | €1,000 | 1 | 0 | 22 September 2026 | 22 September 2026 |

Based on the notices and sources Inteliwert covers; not a complete record.

### Awards

- [Pantoprazol 2026](https://inteliwert.com/tender/opp_SZKD3GGK7VWXQ9BTXXNNJX85VG/pantoprazol-2026)  
  Buyer: Teilnehmende Gesundheitseinrichtungen der EKK plus GmbH und der AGKAMED GmbH · Award value: €1,000 excl. VAT · Awarded: 22 September 2026 · CPV 33600000

## Certifications and prequalification

No certification or prequalification found in the covered sources.

A certification missing here is unknown, not absent.

## Website and LinkedIn

Not found in the indexed notices.

## Open tenders that might fit

*Possible match based on public information*

Companies Inteliwert knows from its sources, not the whole market. Inteliwert does not judge eligibility, fit or chances.

- [Open house Arzneimittelrabattverträge Infliximab, in der Wirkstärke 120mg, ATC L04AB02](https://inteliwert.com/tender/opp_SAPRG822DF0THXF81J2Z8967C9/open-house-arzneimittelrabattvertraege-infliximab-in-der-wirkstaerke-120mg-atc-l)  
  Open · SME (from the award notice) · New to public tenders · Buyer: AOK Bayern - Die Gesundheitskasse · Deadline: 3 Sept 2028, 12:00 (UTC+02:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/c3ad6064-6804-4770-9ad6-c62048bc0c55), Last checked 7 Nov 2026, 18:30 (UTC+01:00)
  - Won a contract in CPV group 336 (2026-09-22): [Evidence](https://inteliwert.com/tender/opp_SZKD3GGK7VWXQ9BTXXNNJX85VG/pantoprazol-2026), checked 7 Nov 2026
  - Seat in the same region as the place of performance: [Evidence](https://inteliwert.com/company/org_QGN97D5B60CD7RK45F910C42EA), checked 7 Nov 2026
  - 1 award in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_SZKD3GGK7VWXQ9BTXXNNJX85VG/pantoprazol-2026), checked 7 Nov 2026
- [Open house Arzneimittelrabattverträge Raloxifen, ATC G03XC01](https://inteliwert.com/tender/opp_1889M4SJTXAA25AJM1MF4XBS4C/open-house-arzneimittelrabattvertraege-raloxifen-atc-g03xc01)  
  Open · SME (from the award notice) · New to public tenders · Buyer: AOK Bayern - Die Gesundheitskasse · Deadline: 3 Sept 2028, 12:00 (UTC+02:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/019318be-7844-4821-b11e-e8fc1b273dde), Last checked 7 Nov 2026, 18:30 (UTC+01:00)
  - Won a contract in CPV group 336 (2026-09-22): [Evidence](https://inteliwert.com/tender/opp_SZKD3GGK7VWXQ9BTXXNNJX85VG/pantoprazol-2026), checked 7 Nov 2026
  - Seat in the same region as the place of performance: [Evidence](https://inteliwert.com/company/org_QGN97D5B60CD7RK45F910C42EA), checked 7 Nov 2026
  - 1 award in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_SZKD3GGK7VWXQ9BTXXNNJX85VG/pantoprazol-2026), checked 7 Nov 2026
- [Open house Arzneimittelrabattverträge Infliximab, ausgenommen in der Wirkstärke 120mg, ATC L04AB02](https://inteliwert.com/tender/opp_EQ4T28ZE6WZ4T8TAT1SGXD5CAW/open-house-arzneimittelrabattvertraege-infliximab-ausgenommen-in-der-wirkstaerke)  
  Open · SME (from the award notice) · New to public tenders · Buyer: AOK Bayern - Die Gesundheitskasse · Deadline: 3 Sept 2028, 12:00 (UTC+02:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/ac93a51c-87c2-4a56-8c80-6f666aecf45e), Last checked 7 Nov 2026, 18:30 (UTC+01:00)
  - Won a contract in CPV group 336 (2026-09-22): [Evidence](https://inteliwert.com/tender/opp_SZKD3GGK7VWXQ9BTXXNNJX85VG/pantoprazol-2026), checked 7 Nov 2026
  - Seat in the same region as the place of performance: [Evidence](https://inteliwert.com/company/org_QGN97D5B60CD7RK45F910C42EA), checked 7 Nov 2026
  - 1 award in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_SZKD3GGK7VWXQ9BTXXNNJX85VG/pantoprazol-2026), checked 7 Nov 2026
- [Open house Arzneimittelrabattverträge Epinephrin, ausgenommen in der nasalen Darreichungsform, ATC C01CA24](https://inteliwert.com/tender/opp_3NNKGQ4W19EPDTDMZEMX83Z5HE/open-house-arzneimittelrabattvertraege-epinephrin-ausgenommen-in-der-nasalen-dar)  
  Open · SME (from the award notice) · New to public tenders · Buyer: AOK Bayern - Die Gesundheitskasse · Deadline: 3 Sept 2028, 12:00 (UTC+02:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/41b979f5-e468-4f1e-b763-4c3e18bb30f6), Last checked 7 Nov 2026, 18:30 (UTC+01:00)
  - Won a contract in CPV group 336 (2026-09-22): [Evidence](https://inteliwert.com/tender/opp_SZKD3GGK7VWXQ9BTXXNNJX85VG/pantoprazol-2026), checked 7 Nov 2026
  - Seat in the same region as the place of performance: [Evidence](https://inteliwert.com/company/org_QGN97D5B60CD7RK45F910C42EA), checked 7 Nov 2026
  - 1 award in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_SZKD3GGK7VWXQ9BTXXNNJX85VG/pantoprazol-2026), checked 7 Nov 2026
- [Open house Arzneimittelrabattverträge Lopinavir und Ritonavir, ATC J05AR10](https://inteliwert.com/tender/opp_ADJZF03Z437KZ14606EAQC39TC/open-house-arzneimittelrabattvertraege-lopinavir-und-ritonavir-atc-j05ar10)  
  Open · SME (from the award notice) · New to public tenders · Buyer: AOK Bayern - Die Gesundheitskasse · Deadline: 3 Sept 2028, 12:00 (UTC+02:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/10634ed3-c5b9-40fd-b489-abf4a3401ed1), Last checked 7 Nov 2026, 18:30 (UTC+01:00)
  - Won a contract in CPV group 336 (2026-09-22): [Evidence](https://inteliwert.com/tender/opp_SZKD3GGK7VWXQ9BTXXNNJX85VG/pantoprazol-2026), checked 7 Nov 2026
  - Seat in the same region as the place of performance: [Evidence](https://inteliwert.com/company/org_QGN97D5B60CD7RK45F910C42EA), checked 7 Nov 2026
  - 1 award in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_SZKD3GGK7VWXQ9BTXXNNJX85VG/pantoprazol-2026), checked 7 Nov 2026
- [Open house Arzneimittelrabattverträge Testosteron, ausgenommen in der Darreichungsform Injektionslösung, ATC G03BA03](https://inteliwert.com/tender/opp_SMEZ9ZSHBPQJR407FZFE8FQ2KV/open-house-arzneimittelrabattvertraege-testosteron-ausgenommen-in-der-darreichun)  
  Open · SME (from the award notice) · New to public tenders · Buyer: AOK Bayern - Die Gesundheitskasse · Deadline: 3 Sept 2028, 12:00 (UTC+02:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/06b184ae-6c7a-4d64-9d0b-7e39c3053dfd), Last checked 7 Nov 2026, 18:30 (UTC+01:00)
  - Won a contract in CPV group 336 (2026-09-22): [Evidence](https://inteliwert.com/tender/opp_SZKD3GGK7VWXQ9BTXXNNJX85VG/pantoprazol-2026), checked 7 Nov 2026
  - Seat in the same region as the place of performance: [Evidence](https://inteliwert.com/company/org_QGN97D5B60CD7RK45F910C42EA), checked 7 Nov 2026
  - 1 award in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_SZKD3GGK7VWXQ9BTXXNNJX85VG/pantoprazol-2026), checked 7 Nov 2026
- [Open house Arzneimittelrabattverträge Nevirapin, ATC J05AG01](https://inteliwert.com/tender/opp_9WHA4N1RBM7CBM98AVCXMBT4YF/open-house-arzneimittelrabattvertraege-nevirapin-atc-j05ag01)  
  Open · SME (from the award notice) · New to public tenders · Buyer: AOK Bayern - Die Gesundheitskasse · Deadline: 3 Sept 2028, 12:00 (UTC+02:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/5d8cbf08-1d4d-4aba-8bc0-61239f0887e0), Last checked 7 Nov 2026, 18:30 (UTC+01:00)
  - Won a contract in CPV group 336 (2026-09-22): [Evidence](https://inteliwert.com/tender/opp_SZKD3GGK7VWXQ9BTXXNNJX85VG/pantoprazol-2026), checked 7 Nov 2026
  - Seat in the same region as the place of performance: [Evidence](https://inteliwert.com/company/org_QGN97D5B60CD7RK45F910C42EA), checked 7 Nov 2026
  - 1 award in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_SZKD3GGK7VWXQ9BTXXNNJX85VG/pantoprazol-2026), checked 7 Nov 2026
- [Open house Arzneimittelrabattverträge Sorafenib, ATC L01EX02](https://inteliwert.com/tender/opp_7ZASJZQA1GSH2A2R3GTGMHZWHH/open-house-arzneimittelrabattvertraege-sorafenib-atc-l01ex02)  
  Open · SME (from the award notice) · New to public tenders · Buyer: AOK Bayern - Die Gesundheitskasse · Deadline: 3 Sept 2028, 12:00 (UTC+02:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/f823de3c-3cbd-483b-b379-89fd22c7042f), Last checked 7 Nov 2026, 18:30 (UTC+01:00)
  - Won a contract in CPV group 336 (2026-09-22): [Evidence](https://inteliwert.com/tender/opp_SZKD3GGK7VWXQ9BTXXNNJX85VG/pantoprazol-2026), checked 7 Nov 2026
  - Seat in the same region as the place of performance: [Evidence](https://inteliwert.com/company/org_QGN97D5B60CD7RK45F910C42EA), checked 7 Nov 2026
  - 1 award in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_SZKD3GGK7VWXQ9BTXXNNJX85VG/pantoprazol-2026), checked 7 Nov 2026
- [Open house Arzneimittelrabattverträge Etanercept, ATC L04AB01](https://inteliwert.com/tender/opp_FBT4HPAESPBYP4510KW3FS9BZ4/open-house-arzneimittelrabattvertraege-etanercept-atc-l04ab01)  
  Open · SME (from the award notice) · New to public tenders · Buyer: AOK Bayern - Die Gesundheitskasse · Deadline: 3 Sept 2028, 12:00 (UTC+02:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/0e862617-da80-4fb3-ac25-9d4a75c15254), Last checked 7 Nov 2026, 18:30 (UTC+01:00)
  - Won a contract in CPV group 336 (2026-09-22): [Evidence](https://inteliwert.com/tender/opp_SZKD3GGK7VWXQ9BTXXNNJX85VG/pantoprazol-2026), checked 7 Nov 2026
  - Seat in the same region as the place of performance: [Evidence](https://inteliwert.com/company/org_QGN97D5B60CD7RK45F910C42EA), checked 7 Nov 2026
  - 1 award in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_SZKD3GGK7VWXQ9BTXXNNJX85VG/pantoprazol-2026), checked 7 Nov 2026
- [Open house Arzneimittelrabattverträge Naproxen, ATC M01AE02](https://inteliwert.com/tender/opp_E06DBSS6TJX4Z7VQ9DQH6RZ3RF/open-house-arzneimittelrabattvertraege-naproxen-atc-m01ae02)  
  Open · SME (from the award notice) · New to public tenders · Buyer: AOK Bayern - Die Gesundheitskasse · Deadline: 3 Sept 2028, 12:00 (UTC+02:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/7704aa4c-482f-46d2-8b64-06d6e16870fe), Last checked 7 Nov 2026, 18:30 (UTC+01:00)
  - Won a contract in CPV group 336 (2026-09-22): [Evidence](https://inteliwert.com/tender/opp_SZKD3GGK7VWXQ9BTXXNNJX85VG/pantoprazol-2026), checked 7 Nov 2026
  - Seat in the same region as the place of performance: [Evidence](https://inteliwert.com/company/org_QGN97D5B60CD7RK45F910C42EA), checked 7 Nov 2026
  - 1 award in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_SZKD3GGK7VWXQ9BTXXNNJX85VG/pantoprazol-2026), checked 7 Nov 2026

## Is this your company?

Send corrections, or ask us to remove the profile, to <hello@inteliwert.com>. You can also ask that the company never be tagged on LinkedIn.

## About this profile

Each fact on this page shows its source: a public notice, an open-data register (GLEIF, Wikidata) or the company’s own website. Inteliwert does not rate companies and does not judge eligibility, fit or chances.

**Based on the notices and sources Inteliwert covers; not a complete record.** Last checked 22 September 2026.

---

Page: https://inteliwert.com/company/org_QGN97D5B60CD7RK45F910C42EA/ever-pharma-gmbh

Inteliwert is a product of Bandpey GmbH, an international data and AI software company in Munich, Germany, founded and led by Roozbeh Bandpey. Bandpey's products: Facthory, Emolysis, Copolly and Inteliwert.

Inteliwert on LinkedIn: https://www.linkedin.com/company/intelliwert, GitHub: https://github.com/inteliwertai.